53.8 F
Laguna Hills
Tuesday, Mar 19, 2024
-Advertisement-

New Ante in Beckman Bidding War for Biosite

The bidding war continues.

A week after Fullerton’s Beckman Coulter Inc. raised its takeover bid for San Diego’s Biosite Inc., rival suitor Inverness Medical Innovations Inc. of Massachusetts upped the ante again Thursday.

Inverness, a maker of medical testing and consumer products, now is offering $92.50 a share for Biosite.

Last week, Beckman raised its bid by $5 a share to match Inverness’ previous offer of $90 a share.

The latest Inverness offer values Biosite at about $1.72 billion.

The public bidding for Biosite, a maker of diagnostic tests for heart diseases and other conditions, started in March when Beckman Coulter offered $85 per share, 53% more than what Biosite was worth before the offer.

The big premium priced in a behind-the-scenes bidding war that included Inverness. The rival suitors now have taken the chase public, with the latest offer from Inverness marking the fourth, including Beckman’s original bid.

Waltham, Mass.-based Inverness already owns 5% of Biosite. On Thursday, Biosite said it plans to hold talks with Inverness about its latest offer.

A spokesman for Beckman declined to comment. Beckman makes machines and supplies for medical testing labs and researchers.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-